CTLA4 and neoplasm: In contrast, both Fc-null and parental 9D9 increased Tregs in tumor-draining lymph nodes (TDLNs, Figure S4A), confirming that peripheral expansion of Tregs is Fc-independent during anti-CTLA-4 therapy.29